Ruth Alon serves as Executive at Silexion Therapeutics Corp, where they oversee executive responsibilities. Since joining the company, Ruth Alon has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 9, 2025 involved receiving (via award) 794 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 9, 2025 | SLXN | $0 | Award | 794 | $N/A | Discretionary |
Ruth Alon currently holds 794 shares of Silexion Therapeutics Corp (SLXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ruth Alon has been a net neutral trader of SLXN stock. They have purchased $0 and sold $0 worth of shares.
Ruth Alon's most recent insider trade was on Feb 9, 2025, when they sold 794 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted